News

As Congress continues to debate health-care reform and how best to pay physicians for providing medical care to the nation's neediest and elderly people, ophthalmologists are increasingly frustrated by the instability it wreaks upon their practices.

Individuals who are visually impaired are more likely to be in a lower socioeconomic bracket in the United States, not to have private insurance, and to have an eye disease that is undetected.

The new Boston Convention and Exhibition Center will house the 2010 annual meetings of the American Society of Cataract and Refractive Surgery, the American Society of Ophthalmic Administrators Congress on ophthalmic practice management, and a program for technicians and nurses, April 9-14.

As everyone knows, the key roles played by vice presidents are to go to funerals and to say things that serve as fodder for comedians.

There is no shortage of studies to measure the costs of visual impairment, but because the studies use a variety of approaches to analyze data, it has been difficult to draw conclusions.

A proprietary surgical microscope allows dynamic control of the red reflex to provide unsurpassed intraocular visualization and to improve the ease and safety of cataract surgery.

The public has until March 5 to submit comments related to presentations made at a Feb. 18 public hearing at which FDA officials discussed challenges related to the premarket notification, or 510(k) process, used to review and clear certain medical devices marketed in the United States.

Lux Biosciences Inc. has submitted simultaneous regulatory filings to the FDA and the European Medicines Agency seeking marketing approval for an investigational drug, oral voclosporin (LUVENIQ or LX211), for the treatment of noninfectious uveitis involving the intermediate or posterior segments of the eye.

The Japanese Ministry of Health, Labor and Welfare has given regulatory approval for STAAR Surgical Co. to market its implantable contact lens (Visian Implantable Collamer Lens) in that country for the treatment of myopia.

Ophthalmic Women Leaders has appointed Pamela Gleeson, chief financial officer of Santen Inc., as its 2010 president. She previously served as chairwoman of the organization?s finance committee.

Bausch + Lomb has unveiled a redesigned company logo and icon. Both incorporate hues of the company?s traditional blue and green colors and introduce the plus symbol instead of the ampersand.

The Brehm Tower at the W.K. Kellogg Eye Center Complex, a $132 million, 230,000-square-foot, eight-story facility, opened March 1. It is adjacent to the existing Kellogg Eye Center research tower.

Compared with sham injections, monthly injections of 0.3 or 0.5 mg of ranibizumab significantly reduced macular edema and improved best-corrected visual acuity in patients with branch retinal vein occlusion.

The Wilmer Eye Institute hosted its 27th annual Current Concepts in Ophthalmology course here March 15 to 19. The event, presented in association with Ophthalmology Times, was designed to focus on clinical use and medical issues important to the constantly evolving practice of ophthalmology.

Minority shareholders of Alcon stock have filed 12 class-action lawsuits protecting Novartis' decision to pay them less than it will pay Nestle for its Alcon shares.

Lessons learned from an ongoing retinal implant program at the University of Southern California are being applied to the development of a novel refillable and programmable drug delivery device that could be used in glaucoma management.